Keyphrases
Vaccination
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Developed Countries
100%
Preventive Strategies
100%
Preadolescents
50%
HPV16
33%
Adolescent Females
33%
Cost-effectiveness
16%
Papillomavirus Infections
16%
Screening Recommendations
16%
Cervical Cancer
16%
Vaccine Uptake
16%
Cervical Cancer Screening
16%
Comprehensive Evaluation
16%
Return on Investment
16%
Vaccination Coverage
16%
Screening Strategy
16%
Population Impact
16%
Human Papillomavirus Testing
16%
Prevention Methods
16%
Unvaccinated
16%
Prophylactic Vaccination
16%
Comprehensive Control
16%
Adolescent Males
16%
Screening Interval
16%
Non-live Vaccines
16%
Cross-protection
16%
Imperfect Compliance
16%
Quadrivalent
16%
Screening Uptake
16%
Specific Level
16%
Screening Participation
16%
Potential Trade
16%
Anogenital Warts
16%
Medicine and Dentistry
Health Care Cost
100%
Human Papillomavirus Related Disease
100%
Pre-Adolescent
75%
Wart Virus
50%
Human Papillomavirus Type 16
50%
Disease
25%
Cost-Effectiveness Analysis
25%
Infection
25%
Screening
25%
Cervical Cancer
25%
Papillomavirus Infection
25%
Genital Wart
25%
Cross Protection
25%
Cervical Screening
25%
Vaccination Coverage
25%